BioCentury
ARTICLE | Company News

Cambridge Antibody, Weston deal

April 2, 2001 7:00 AM UTC

The companies expanded their existing deal to evaluate delivery of CAT's CAT-192 antibody in WMG's Intraject needleless injection device to include preclinical and clinical and development (see BioCen...